MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments-Reference-Cited by-同舟云学术

MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments

Published:2011-10 Issue:10 Volume:86 Page:948-955
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Tepper Stewart J.,Kori Shashidhar H.,Goadsby Peter J.,Winner Paul K.,Wang Min H.,Silberstein Stephen D.,Cutrer F. Michael

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. The global burden of headache: a documentation of headache prevalence and disability worldwide;Stovner;Cephalalgia,2007

2. The International Classification of Headache Disorders: 2nd edition;Headache Classification Subcommittee of the International Headache Society;Cephalalgia,2004

3. Early treatment of acute migraine: new evidence of benefits;Valade;Cephalalgia,2009

4. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe;Cady;Curr Med Res Opin,2004

5. Efficacy of rizatriptan 10 mg administered early in a migraine attack;Cady;Headache,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults;Expert Review of Neurotherapeutics;2024-04-24

2. Medication “underuse” headache;Cephalalgia;2024-04

3. Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure;The Journal of Headache and Pain;2022-11-22

4. STOP 301: A Phase 3, open‐label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD ® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients;Headache: The Journal of Head and Face Pain;2021-08-07

5. Formulation and evaluation of inhalable microparticles of Rizatriptan Benzoate processed by spray freeze-drying;Journal of Drug Delivery Science and Technology;2021-04